Atlas Trials

Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

Clinical trial NCT00416819 · COMPLETED

Trial details

NCT number
NCT00416819
Sponsor
University of California, San Francisco
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Brain and Central Nervous System TumorsLymphoma
Start date
2003-09-01
Primary completion
2005-12-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.